Diagram of inner ear anatomy showing endolymph hydrops and increased fluid pressure in the semicircular canals, vestibule, and cochlea
Navigating Ménière’s Disease & Ménière’s Syndrome: A Clinical Guide to Endolymphatic Hydrops

Ménière’s disease and Ménière’s syndrome share an identical symptom complex characterized by inner-ear dysfunction. The critical diagnostic boundary rests entirely on etiology: Ménière’s disease is idiopathic, whereas Ménière’s syndrome stems from an identifiable underlying pathology.

Etiology & Core Pathophysiologic Mechanism

  • Ménière’s Disease vs. Syndrome:
    • Ménière’s Disease: Idiopathic endolymphatic hydrops without a recognizable secondary cause. Peak incidence occurs between 40–60 years of age with a slight female predominance.
    • Ménière’s Syndrome: Endolymphatic hydrops secondary to a known systemic or localized disorder (e.g., systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], otosclerosis, or post-traumatic/viral labyrinthitis).
  • Core Mechanism (Endolymphatic Hydrops):
    ↑ Endolymphatic Fluid Volume/Pressure → Membrane Distortion & Rupture → Dual Dysfunction: Cochlear System (Fluctuating Hearing Loss & Tinnitus) + Vestibular System (Vertigo & Imbalance)
  • Common Flare Triggers: High dietary sodium, caffeine, alcohol, elevated physical/emotional stress, and menstrual cycle variations.

1. The Classic Diagnostic Tetrad

Tetrad Feature Clinical Presentation & Progression Key Diagnostic Pearls
1. Episodic Vertigo Recurrent room-spinning vertigo lasting minutes to hours (typically 20 min to 24 hours). Accompanied by severe nausea, profuse vomiting, and post-episode exhaustion. Must be distinguished from brief position-induced episodes (<1 min in BPPV) or continuous multi-day vertigo (vestibular neuritis).
2. Fluctuating Hearing Loss Progressive Sensorineural Hearing Loss (SNHL) that heralds or accompanies acute vertigo flares. Early loss affects low-to-moderate frequencies; advances to high frequencies over time. Unilateral in early disease; audiometry confirms SNHL. Reversible initially, but permanent loss accrues over years.
3. Tinnitus Low-pitched ringing, roaring, or buzzing tone that characteristically fluctuates in intensity prior to or during an acute attack. Roaring character distinguishes it from high-pitched tonal tinnitus common in presbycusis or noise exposure.
4. Aural Fullness Deep, uncomfortable sensation of pressure, fullness, or a “plugged” ear on the affected side prior to or during exacerbations. Reflects increased hydraulic pressure within the membranous labyrinth.

2. Bedside & Diagnostic Examination Strategies

Diagnostic Test Expected Clinical Finding Diagnostic Significance & Interpretation
Weber Tuning Fork Test Sound lateralizes to the unaffected (better) ear. Confirms sensorineural hearing loss in the affected ear (sound travels to the functional inner ear).
Rinne Tuning Fork Test Air Conduction > Bone Conduction (AC > BC) bilaterally. Normal/Positive result; excludes conductive middle-ear pathology.
Fukuda Marching Step Test Progressive rotational drift toward the affected (faulty) ear. Identifies unilateral vestibular tone deficit as the patient marches in place with eyes closed.
Romberg Test Positive (increased unsteadiness/sway with eyes closed). Demonstrates proprioceptive and vestibular imbalance.
Pneumatic Otoscopy Pressure changes elicit vertigo or nystagmus (Hennebert’s sign). Suggests abnormal mechanical coupling between the middle and inner ear.
Dix-Hallpike Maneuver Typically negative; may be weakly positive. A strongly positive result with classic torsional nystagmus indicates coexisting BPPV.
Neuroimaging (CT/MRI) Unremarkable for structural defects. Not routinely required unless needed to rule out central pathology or vestibular schwannoma (acoustic neuroma).

3. Phase-Specific Management & Treatment Protocols

Phase / Goal Therapeutic Class & Agents Clinical Mechanics & Safety Warnings
Acute Attack Control
Rescue Therapy
Vestibular Suppressants: Meclizine (Antihistamine) or Benzodiazepines (Diazepam).
Antiemetics: Ondansetron or Promethazine.
Corticosteroids: Short-term oral Prednisone taper.
Controls disabling vertigo, nausea, and anxiety during acute attacks. Corticosteroids reduce inner-ear endolymphatic inflammation and preserve hearing. Does not prevent future attacks.
Attack Prevention
Maintenance
Diuretics: Thiazides (e.g., Hydrochlorothiazide/Triamterene).
Lifestyle Modification: Low-salt diet (<2,000 mg/day), caffeine & alcohol restriction, stress reduction.
Lowers endolymphatic volume and hydraulic pressure. Thiazides are for prophylaxis only; they have no role in terminating an acute attack.
Refractory / Invasive ENT Options
Specialist Level
Conservative Procedures: Endolymphatic sac decompression.
Ablative Therapies: Intratympanic Gentamicin (chemical labyrinthectomy), vestibular neurectomy, or surgical labyrinthectomy.
Reserved for intractable, disabling vertigo failing conservative measures. Warning: Ablative procedures carry a high risk of permanent sensorineural hearing loss.
Secondary Disease Control Targeted therapy for underlying disorder (e.g., immunosuppressants for SLE/RA). Essential in Ménière’s syndrome to halt ongoing secondary labyrinthine damage.

4. High-Yield Clinical Comparisons

Clinical Feature Ménière’s Disease Benign Paroxysmal Positional Vertigo (BPPV)
Vertigo Duration Episodic, lasting minutes to hours (20 min – 24 hr). Brief paroxysmal attacks, lasting <1 minute.
Auditory Symptoms PRESENT ⭐ (Hearing loss, tinnitus, aural fullness). ABSENT.
Dix-Hallpike Test Usually negative (unless concurrent BPPV). Classically Diagnostic (rotational nystagmus with latency).
Primary Triggers Sodium intake, stress, or spontaneous pressure shifts. Specific head-position changes (e.g., rolling over in bed, looking up).

Primary Clinical Separator

Vertigo paired with auditory symptoms (hearing loss, tinnitus, or aural fullness) points directly to Ménière’s Disease/Syndrome rather than BPPV or vestibular neuritis.

High-Yield Exam & Practice Pearls

  • Disease vs. Syndrome: Disease = Idiopathic endolymphatic hydrops; Syndrome = Secondary endolymphatic hydrops (e.g., SLE, RA).
  • The Classic Tetrad: Episodic vertigo + fluctuating SNHL + tinnitus + aural fullness.
  • Tuning Fork Pattern: Sensorineural loss → Weber lateralizes to the UNAFFECTED (good) ear; Rinne is normal bilaterally (AC > BC).
  • Gait Directionality: Fukuda step test shows rotational drift toward the AFFECTED (faulty) ear.
  • Diuretic Utility: Thiazide diuretics are strictly for prevention of attacks; they are useless for acute symptom termination.
  • Rescue Therapy: Meclizine, antiemetics, benzodiazepines, and short courses of steroids manage acute exacerbations.

Board Exam Recall: Ménière’s etiology = Endolymphatic hydrops (excess inner-ear fluid) | Classic tetrad = Vertigo (mins-hrs) + fluctuating SNHL + tinnitus + aural fullness | Weber test = Lateralizes to good ear | Fukuda test = Drift toward affected ear | Prevention tx = Thiazide diuretics + low-sodium diet | Acute attack tx = Meclizine / Benzodiazepines / Steroids | Differential rule = Auditory symptoms + vertigo rules out BPPV. Prepared strictly for healthcare educational purposes.

Published on
September 12, 2026
|
Last Reviewed on
September 17, 2026
Connecting You and Primary Care
© 2026 TME HEALTHCARE. All rights reserved.